Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal

Published:2023-09-01 Issue:25 Volume:41 Page:4093-4096
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Bestvina Christine M.¹^ORCID,Garassino Marina C.¹^ORCID,Neal Joel W.²^ORCID,Wakelee Heather A.²^ORCID,Diehn Maximilian³,Vokes Everett E.¹^ORCID

Affiliation:

1. Department of Medicine, Section of Hematology/Oncology, Comprehensive Cancer Center, University of Chicago, Chicago, IL

2. Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA

3. Department of Radiation Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.23.00258

Reference29 articles.

1. When immunotherapy meets surgery in non-small cell lung cancer

2. Neoadjuvant therapy gains FDA approval in non-small cell lung cancer

3. Neoadjuvant and Adjuvant Systemic Therapy for Early-Stage Non-small-Cell Lung Cancer

4. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

5. Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non‐small cell lung cancer;International Journal of Cancer;2024-06-20

2. A Single-Center Experience in Combined Oncological–Surgical Treatment for Resectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC);Diseases;2024-05-12

3. Neoadjuvant Chemo-Immunotherapy for Early-Stage Non–Small Cell Lung Cancer;JAMA Network Open;2024-04-16

4. Challenges and controversies in resectable non-small cell lung cancer: a clinician’s perspective;The Lancet Regional Health - Europe;2024-03

5. New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe;The Lancet Regional Health - Europe;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3